Cas:14771-77-8 3-propan-2-ylpiperazine-2,5-dione manufacturer & supplier

We serve Chemical Name:3-propan-2-ylpiperazine-2,5-dione CAS:14771-77-8 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.

3-propan-2-ylpiperazine-2,5-dione

Chemical Name:3-propan-2-ylpiperazine-2,5-dione
CAS.NO:14771-77-8
Synonyms:HMS1664L18;2,5-Piperazinedione, 3-(1-methylethyl)-;3-isopropylpiperazine-2,5-dione;c-Gly-L-Val;3-Isopropyl-2,5-piperazinedione;3-Isopropyl-2,5-piperazine-dione
Molecular Formula:C7H12N2O2
Molecular Weight:156.182
HS Code:2933599090

Physical and Chemical Properties:
Melting point:N/A
Boiling point:445.7±38.0 °C at 760 mmHg
Density:1.1±0.1 g/cm3
Index of Refraction:1.459
PSA:65.18000
Exact Mass:156.089874
LogP:-1.19

Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:


Contact us for information like HMS1664L18 chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,3-Isopropyl-2,5-piperazine-dione physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,c-Gly-L-Val Use and application,3-isopropylpiperazine-2,5-dione technical grade,usp/ep/jp grade.


Related News: As a result, the team identified and prioritized studies that would provide the necessary product and process understanding needed to develop a control strategy, ensure the reproducibility of the product, and meet its intended safety, efficacy, stability, and performance profile regardless of the manufacturing scale. 4-ethoxy-1-isopropyl-N,N-dimethyl-2-phenyl-3-(phenylethynyl)cyclopenta-2,4-dien-1-amine manufacturers The FDA has already clashed with COVID vaccine heavyweights Pfizer and BioNTech over the immediate need for boosters for the broader population. While the drugmakers argue a third shot would offer the highest level of protection, both the CDC and FDA immediately came out against that assertion. 1,3,6,9-tetraphenyl-1,3,6,9-tetrazaspiro[4.4]nonane-2,4-dione suppliers The review considered two cases of AML in patients treated with an investigational medicine, bb1111, in a clinical trial for sickle cell disease. Although there have been no reports of AML with Zynteglo, both medicines use the same viral vector and there was a concern that the vector may be implicated in the development of the cancer (insertional oncogenesis). Oxygenase, methane mono- (uncultured methanotrophicproteobacterium clone B75 gene pmoA) vendor & factory.